Bortezomib-melphalan conditioning regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bortezomib-melphalan conditioning regimen, covering 2022-05-23 to 2022-05-23. Get the full timeline:
Most recent: Clinical Trial Update: Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma [Phase 3]